Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase 2 Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of PD-(L)1 Resistant Malignant Melanoma

The protocol is a Simon's 2-stage, non-randomized, open label, multi-site, phase 2 trial for patients with advanced metastatic, recurrent and unresectable mali…

Malignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more

Rapa Therapeutics LLCNCT06708455